Dr. Greg Riely on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment
Dr. Greg Riely: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing
Dr. Greg Riely: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?
Dr. Greg Riely on "My Approach to Maintenance Therapy for Advanced NSCLC"
Dr. Greg Riely: How I Use Molecular Marker Information in Earlier Stage NSCLC Patients
Dr. Greg Riely: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers?
Dr. Greg Riely on Muliplex Next Generation Sequencing and its Effect on Molecular Oncology Practice
Dr. Greg Riely on "Which patients do you send molecular marker testing for, and what tests do you seek?"
The Potential Value of Repeat Biopsies in Acquired Resistance
Scopri di più
Cerca
